BRIGHTEN OPTIX CORPORATION Brighten Optix Corporation Stock
Equities
6747
TW0006747009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175 TWD | -0.57% |
|
-4.11% | -7.65% |
| Sales 2024 * | 207M 28.61M 930M | Sales 2025 * | 234M 32.35M 1.05B | Capitalization | 941M 130M 4.22B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 4.54 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.02 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
6.34% | Yield 2025 * |
7.08% | Free-Float | 33.42% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.57% | ||
| 1 week | -4.11% | ||
| Current month | -6.67% | ||
| 1 month | -7.89% | ||
| 3 months | -5.15% | ||
| 6 months | -4.11% | ||
| Current year | -7.65% |
1 week
174.00
180.00
1 month
174.00191.50
Current year
174.00194.00
1 year
174.00250.00
3 years
163.00479.50
5 years
72.00479.50
10 years
72.00479.50
| Managers | Title | Age | Since |
|---|---|---|---|
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
Chu Yin Yeh
DFI | Director of Finance/CFO | - | - |
Yi Tsung Wu
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shih Fang Chiu
BRD | Director/Board Member | - | 19-09-19 |
Che Yu Li
BRD | Director/Board Member | - | 19-09-19 |
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 175 | -0.57% | 50,125 |
| 24-04-22 | 176 | -0.28% | 29,862 |
| 24-04-19 | 176.5 | -1.94% | 36,447 |
| 24-04-18 | 180 | 0.00% | 34,631 |
| 24-04-17 | 180 | -1.37% | 82,001 |
End-of-day quote Taipei Exchange, April 22, 2024
More quotes
BRIGHTEN OPTIX CORPORATION is a Taiwan-based company principally engaged in the manufacture and sale of contact lenses. The Company is engaged in the manufacture of custom-made hard contact lenses, custom-made soft contact lenses, as well as the agency, distribution and sale of contact lens care products. The custom-made hard contact lenses include Rigid Gas-Permeable Lens and Orthokeratology Lenses. The Company distributes its products mainly in China.
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
38.92
CNY
Average target price
51.43
CNY
Spread / Average Target
+32.13%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.65% | 130M | |
| +12.78% | 97.69B | |
| +12.40% | 39.6B | |
| -3.10% | 17.9B | |
| -23.03% | 2.12B | |
| -4.96% | 1.46B | |
| +21.69% | 1.09B | |
| -38.53% | 759M | |
| -35.65% | 740M | |
| -12.09% | 613M |
- Stock Market
- Equities
- 6747 Stock
